Therapeutic Asset Ratings
124 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Nivolumab
Advanced Malignant Solid Neoplasm
National Cancer Institute (NCI)
P2
BB
(64)
Olaparib
Advanced Malignant Solid Neoplasm
National Cancer Institute (NCI)
P2
BB
(64)
Palbociclib
Advanced Malignant Solid Neoplasm
National Cancer Institute (NCI)
P2
BB
(64)
Carboplatin
Advanced Malignant Solid Neoplasm
OHSU Knight Cancer Institute
P2
B
(63)
CIS-DIAMMINEDICHLOROPLATINUM II
Advanced Malignant Solid Neoplasm
National Cancer Institute (NCI)
P2
B
(63)
Vinorelbine
Advanced Malignant Solid Neoplasm
OHSU Knight Cancer Institute
P2
B
(63)
Suvorexant
Advanced Malignant Solid Neoplasm
Mayo Clinic
P4
B
(62)
Olanzapine
Advanced Malignant Solid Neoplasm
OHSU Knight Cancer Institute
P3
B
(62)
Bet Bromodomain Inhibitor Zen-3694
Advanced Malignant Solid Neoplasm
National Cancer Institute (NCI)
P2
B
(62)
Cediranib
Advanced Malignant Solid Neoplasm
National Cancer Institute (NCI)
P2
B
(62)
Eloxatin
Advanced Malignant Solid Neoplasm
National Cancer Institute (NCI)
P2
B
(62)
Letrozole
Advanced Malignant Solid Neoplasm
OHSU Knight Cancer Institute
P2
B
(62)
TRASTUZUMAB
Advanced Malignant Solid Neoplasm
OHSU Knight Cancer Institute
P2
B
(62)
Trastuzumab Emtansine
Advanced Malignant Solid Neoplasm
OHSU Knight Cancer Institute
P2
B
(62)
Cyclophosphamide
Advanced Malignant Solid Neoplasm
M.D. Anderson Cancer Center
P2
B
(61)
Epirubicin
Advanced Malignant Solid Neoplasm
M.D. Anderson Cancer Center
P2
B
(61)
FULVESTRANT
Advanced Malignant Solid Neoplasm
National Cancer Institute (NCI)
P2
B
(61)
Pembrolizumab
Advanced Malignant Solid Neoplasm
M.D. Anderson Cancer Center
P2
B
(61)
Veliparib
Advanced Malignant Solid Neoplasm
National Cancer Institute (NCI)
P2
B
(61)
AZD1775
Advanced Malignant Solid Neoplasm
National Cancer Institute (NCI)
P2
B
(60)
Everolimus
Advanced Malignant Solid Neoplasm
M.D. Anderson Cancer Center
P2
B
(60)
gsk1120212
Advanced Malignant Solid Neoplasm
M.D. Anderson Cancer Center
P2
B
(59)
5-azacytidine
Advanced Malignant Solid Neoplasm
M.D. Anderson Cancer Center
P2
B
(58)
Alpelisib
Advanced Malignant Solid Neoplasm
National Cancer Institute (NCI)
P2
B
(58)
Calcium folinate pentahydrate
Advanced Malignant Solid Neoplasm
National Cancer Institute (NCI)
P2
B
(58)
Showing 1 to 25 of 124 assets
Previous
Page 1 of 5
Next